Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Regulatory Lymphocytes Are Key Factors in MHC-Independent Resistance to EAE.
Hyaluronan Anchored to Activated CD44 on CNS Vascular Endothelial Cells Promotes Lymphocyte Extravasation in Experimental Autoimmune Encephalomyelitis.
Exploring the Role of Nerve Growth Factorin Multiple Sclerosis: Implications in Myelin Repair.
Elevated levels of PPAR-gamma in the cerebrospinal fluid of patients with multiple sclerosis.
Endurance training is feasible in severely disabled patients with progressive multiple sclerosis.
Axonal Guillain-Barré syndrome: concepts and controversies.
Lower Serum Levels of Th2-Related Chemokine CCL22 in Women Patients with Multiple Sclerosis: A Comparison Between Patients and Healthy Women.
Risk evaluation and monitoring in multiple sclerosis therapeutics.
'Spinal amaurosis' (1841). On the early contribution of Edward Hocken to the concept of neuromyelitis optica.
Retrograde degeneration of visual pathway: hemimacular thinning of retinal ganglion cell layer in progressive and active multiple sclerosis.
Non-invasive Brain Stimulation Therapy in Multiple Sclerosis: A Review of tDCS, rTMS and ECT Results.
Multiple Sclerosis.
New markers of early cardiovascular risk in multiple sclerosis patients: Oxidized-LDL correlates with clinical staging.
Apolipoprotein E and its mimetic peptide suppress Th1 and Th17 responses in experimental autoimmune encephalomyelitis.
Novel Therapeutic Approach by Nicotine in Experimental Model of Multiple Sclerosis.
Acute disseminated encephalomyelitis following biting by a scolopendra subspinipes mutilans.
Update on monitoring and adverse effects of approved second-generation disease-modifying therapies in relapsing forms of multiple sclerosis.
MRI pattern in asymptomatic natalizumab-associated PML.
High-resolution melting analysis for mutation scanning in the non-coding control region of JC polyomavirus from patients with progressive multifocal leukoencephalopathy.
Genetic pleiotropy between multiple sclerosis and schizophrenia but not bipolar disorder: differential involvement of immune-related gene loci.
Multiple sclerosis in New Zealand.
How are cognitive impairment, fatigue and signs of depression related to participation in daily life among persons with multiple sclerosis?
Strategies used by individuals with multiple sclerosis and with mild disability to maintain dynamic stability during a steering task.
2-Cyclopropylimino-3-Methyl-1,3-Thiazoline Hydrochloride Inhibits Microglial Activation by Suppression of Nuclear Factor-Kappa B and Mitogen-Activated Protein Kinase Signaling.
Experience of gratitude, awe and beauty in life among patients with multiple sclerosis and psychiatric disorders.
Pages
« first
‹ previous
…
457
458
459
460
461
462
463
464
465
…
next ›
last »